1970
DOI: 10.1007/bf01900425
|View full text |Cite
|
Sign up to set email alerts
|

Griseofulvin resistance in dermatophytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1973
1973
2017
2017

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…60% only have been noted (19). Griseofulvin-resistant isolates have been obtained from clinical sources and from laboratory mutagenesis experiments (18,19,150,160); however, some cases of apparent resistance may be due to host factors (215). Ketoconazole has been used and has a lower relapse rate (99,115) but a greater chance of inducing side effects, such as hepatotoxicity and depressed adrenal activity (200).…”
Section: Tinea Corporismentioning
confidence: 99%
“…60% only have been noted (19). Griseofulvin-resistant isolates have been obtained from clinical sources and from laboratory mutagenesis experiments (18,19,150,160); however, some cases of apparent resistance may be due to host factors (215). Ketoconazole has been used and has a lower relapse rate (99,115) but a greater chance of inducing side effects, such as hepatotoxicity and depressed adrenal activity (200).…”
Section: Tinea Corporismentioning
confidence: 99%
“…Griseofulvin One of the first reported studies of clinical drug resistance against griseofulvin was in the dermatophyte Microsporum gypseum (Lenhart 1970). Two different unlinked loci, grf-1 and grf-2, were identified that were found to be associated with drug resistance in this pathogen.…”
Section: Drug Resistance In Dermatophytesmentioning
confidence: 99%